BX Swiss TOP 30 CHF
1.276,51
PKT
+5,72
PKT
+0,45
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
17.07.15 | UBS Hold | Deutsche Bank AG | |
16.07.15 | Nestlé overweight | JP Morgan Chase & Co. | |
16.07.15 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
16.07.15 | Givaudan Neutral | Citigroup Corp. | |
16.07.15 | Holcim Neutral | UBS AG | |
15.07.15 | Holcim overweight | JP Morgan Chase & Co. | |
15.07.15 | UBS Neutral | UBS AG | |
15.07.15 | UBS Outperform | RBC Capital Markets | |
14.07.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
14.07.15 | UBS overweight | JP Morgan Chase & Co. | |
14.07.15 | UBS overweight | JP Morgan Chase & Co. | |
14.07.15 | Swiss Re Underweight | JP Morgan Chase & Co. | |
14.07.15 | Nestlé overweight | JP Morgan Chase & Co. | |
14.07.15 | Swiss Re buy | Goldman Sachs Group Inc. | |
14.07.15 | Roche buy | UBS AG | |
13.07.15 | UBS overweight | Morgan Stanley | |
13.07.15 | UBS overweight | Morgan Stanley | |
13.07.15 | Novartis buy | Citigroup Corp. | |
13.07.15 | Novartis buy | Jefferies & Company Inc. | |
13.07.15 | Roche buy | Jefferies & Company Inc. | |
13.07.15 | Zurich Insurance Neutral | Citigroup Corp. | |
10.07.15 | Givaudan Hold | Société Générale Group S.A. (SG) | |
10.07.15 | Novartis buy | UBS AG | |
10.07.15 | Swiss Re Equal weight | Barclays Capital | |
10.07.15 | Zurich Insurance overweight | Barclays Capital | |
10.07.15 | Givaudan Neutral | BNP PARIBAS | |
09.07.15 | Novartis overweight | JP Morgan Chase & Co. | |
09.07.15 | Holcim buy | Deutsche Bank AG | |
09.07.15 | Nestlé Reduce | Nomura | |
09.07.15 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
08.07.15 | Nestlé Hold | Deutsche Bank AG | |
08.07.15 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
08.07.15 | Holcim overweight | JP Morgan Chase & Co. | |
08.07.15 | Roche overweight | JP Morgan Chase & Co. | |
07.07.15 | UBS overweight | JP Morgan Chase & Co. | |
07.07.15 | UBS overweight | JP Morgan Chase & Co. | |
07.07.15 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
07.07.15 | Novartis buy | UBS AG | |
06.07.15 | Givaudan buy | Deutsche Bank AG | |
06.07.15 | Novartis overweight | JP Morgan Chase & Co. |